CAXTON CORP Diversified Active

CIK: 0001388551 · Show all filings

Period: Q4 2014 (← Previous) (Next →)

Filing Date: Feb 17, 2015

Total Value ($000): $86,926 (100.0% shares, 0.0% debt)

Holdings (10)

— SYNTA PHARMACEUTICALS CORP 92.1%

Value ($000) $80,025 Shares 30,197,945 Est. Cost $7.71 Unrealized —

— CELATOR PHARMACEUTICALS INC 5.1%

Value ($000) $4,403 Shares 2,246,469 Est. Cost $3.25 Unrealized —

ALKS ALKERMES PLC 1.4%

Value ($000) $1,220 Shares 20,825 Est. Cost $50.94 Unrealized 0.0%

PSEC PROSPECT CAPITAL CORPORATION 0.5%

Value ($000) $454 Shares 55,012 Est. Cost $2.34 Unrealized 0.0%

SLRC SOLAR CAP LTD 0.2%

Value ($000) $198 Shares 11,002 Est. Cost $6.52 Unrealized 0.0%

— AGILE THERAPEUTICS INC 0.2%

Value ($000) $182 Shares 29,645 Est. Cost $8.40 Unrealized —

— MEDLEY CAP CORP 0.2%

Value ($000) $152 Shares 16,503 Est. Cost $9.21 Unrealized —

— CM FIN INC 0.1%

Value ($000) $124 Shares 11,259 Est. Cost $11.01 Unrealized —

— EATON VANCE SR INCOME TR 0.1%

Value ($000) $96 Shares 15,403 Est. Cost $6.23 Unrealized —

— NUVEEN SR INCOME FD 0.1%

Value ($000) $72 Shares 11,002 Est. Cost $6.54 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	SYNTA PHARMACEUTICALS CORP	30,197,945	$80,025	92.1%	$7.71	—	COM	87162T206
—	CELATOR PHARMACEUTICALS INC	2,246,469	$4,403	5.1%	$3.25	—	COM	15089R102
ALKS	ALKERMES PLC	20,825	$1,220	1.4%	$50.94	0.0%	SHS	G01767105
PSEC	PROSPECT CAPITAL CORPORATION	55,012	$454	0.5%	$2.34	0.0%	COM	74348T102
SLRC	SOLAR CAP LTD	11,002	$198	0.2%	$6.52	0.0%	COM	83413U100
—	AGILE THERAPEUTICS INC	29,645	$182	0.2%	$8.40	—	COM	00847L100
—	MEDLEY CAP CORP	16,503	$152	0.2%	$9.21	—	COM	58503F106
—	CM FIN INC	11,259	$124	0.1%	$11.01	—	COM	12574Q103
—	EATON VANCE SR INCOME TR	15,403	$96	0.1%	$6.23	—	SH BEN INT	27826S103
—	NUVEEN SR INCOME FD	11,002	$72	0.1%	$6.54	—	COM	67067Y104